04/09/2026
Rosacea is a chronic inflammatory dermatosis affecting ~10% of the population worldwide. While guidelines recommend oral antibiotics with topical anti-inflammatory agents for moderate-to-severe disease, treatment resistance is common, prompting off-label options like low-dose isotretinoin (LDI). This systematic review evaluates LDI dosing, duration, and efficacy: https://bit.ly/4sdRRbg